Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE1513.0514.55 (+0.97 %)
PREV CLOSE () 1498.50
OPEN PRICE () 1498.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8383
TODAY'S LOW / HIGH ()1498.15 1517.00
52 WK LOW / HIGH ()1317.6 1702
NSE1512.0512.9 (+0.86 %)
PREV CLOSE() 1499.15
OPEN PRICE () 1499.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1512.05 (349)
VOLUME 984355
TODAY'S LOW / HIGH() 1495.45 1517.60
52 WK LOW / HIGH ()1317.25 1702.05
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1935

Management Info :

Y K Hamied - Chairman Umang Vohra - Managing Director

Registered Office :

Address : Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel,
Mumbai,
Maharashtra-400013

Phone : 022-24826000

Website : www.cipla.com

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg
NEWS
24Feb Cipla rises on the bourses
Cipla is currently trading at Rs. 1475.50, up by 1.20 points or 0.08% fr..
21Feb USFDA concludes cGMP inspection at ana
United States Food and Drugs Administration (USFDA) has concluded a curr..
21Feb Cipla gets USFDA’s final nod for Nilot
Cipla has received final approval from the United States Food and Drug A..
21Feb Cipla declines on the BSE
Cipla is currently trading at Rs. 1476.10, down by 3.70 points or 0.25%..
21Feb USFDA Inspection At Analytical Testin
USFDA inspection at analytical testing facility of Sitec Labs Limited in..
Financials
in Millions
QTR Dec 24 ANNUAL 24
Net Profit14381.540772.5
Gross Profit 17043.5 49469.7
Operating Profit 18505.255548.1
Net Sales 49708.8165743.4
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma I (BSE)
 8391.50 (6.21%)
M.Cap ( in Cr)
20978.75
Neuland Laboratories (BSE)
 11676.90 (1.44%)
M.Cap ( in Cr)
14981.33
Procter&Gamble Healt (BSE)
 5333.00 (2.08%)
M.Cap ( in Cr)
8852.45
Sanofi India (BSE)
 5702.95 (1.62%)
M.Cap ( in Cr)
13134.25
Mankind Pharma (BSE)
 2246.00 (3.91%)
M.Cap ( in Cr)
92665.14
Shareholding Pattern
PROMOTERS 29.19%
MUTUAL FUNDS/UTI 20.46%
NON-INSTITUTION 16.52%
FI/BANKS/INSURANCE 5.29%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX76348.06899.01 (1.19%)
NIFTY23190.65283.05 (1.24%)
Dow Jones 41964.63383.32 (0.92%)
Nasdaq 17750.79246.67 (1.41%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI